MedTrace Logo

Effect and Utilization of Protected Time Among Interns on Extended Duty-Hour Call Shifts

NCT00983008 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 11

Last updated 2019-09-26

No results posted yet for this study

Summary

This study will test the feasibility and effectiveness of protected time for physicians in training during 30 hour shifts in a medical intensive care unit. The primary outcome will be fatigue. Secondary outcomes include the amount slept while on call, depression, and burnout.

Conditions

Interventions

BEHAVIORAL

Protected time and Dedicated time

On Sunday through Thursday nights medical intensive care unit interns will have a 5 hour protected period from 2 to 7 am. During this time they will relinquish their pager and cell phone to the Night Float PGY2 or PGY3 who is already responsible for the ICU patients. The four hours between 2 and 6 am are entirely protected. 6 AM to 7 AM is dedicated time during which the interns will be expected to start pre-rounding on the ICU patients and to begin progress notes for the remaining members of the ICU team but still have no pager, cell phone, or cross coverage duties. On Friday and Saturday nights there will be no protected time but these interns will have 42 consecutive hours off following their extended shifts.

Sponsors & Collaborators

  • Providence Health & Services

    lead OTHER

Principal Investigators

  • Gerald Dunlap, M.D. · Internal Medicine Resident Program, Providence St. Vincent Medical Center

  • Michelle Sanders, M.D. · Internal Medicine Resident Program, Providence St. Vincent Medical Center

  • Jay B Ham, M.D. · Internal Medicine Resident Program, Providence St. Vincent Medical Center

  • Jeffrely Bluhm, M.D. · Oregon Pulmonology Associates, Portland, Oregon

Study Design

Allocation
NA
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-10-31
Primary Completion
2010-09-30
Completion
2010-09-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00983008 on ClinicalTrials.gov